We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen Asks High Court To Hear Landmark Case

Law360 (March 22, 2007, 12:00 AM EDT) -- Seeking a high profile review of the 12-year old Markman rule, biotech company Amgen Inc. asked the U.S. Supreme Court on Thursday to decide whether a federal appeals court should give deference to findings made by a trial court during claim construction.

If accepted, Amgen’s case would allow the Supreme Court to signal to the U.S. Court of Appeals for the Federal Circuit whether its decision-making is on track with the law—not to mention revive Amgen’s patent infringement case against French rival Sanofi-Aventis.

Amgen’s petition asks...
To view the full article, register now.